169 related articles for article (PubMed ID: 36610166)
1. Tilianin improves lipid profile and alleviates atherosclerosis in ApoE
Du Y; Xi M; Li Y; Zheng R; Ding X; Li X; Zhang X; Wang L; Xing J; Hong B
Phytomedicine; 2023 Jan; 109():154577. PubMed ID: 36610166
[TBL] [Abstract][Full Text] [Related]
2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
3. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.
Bai X; Wang S; Shu L; Cao Q; Hu H; Zhu Y; Chen C
J Ethnopharmacol; 2024 Jun; 327():118006. PubMed ID: 38442806
[TBL] [Abstract][Full Text] [Related]
4. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S
Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
6. Quinic acid regulated TMA/TMAO-related lipid metabolism and vascular endothelial function through gut microbiota to inhibit atherosclerotic.
Jin Q; Zhang C; Chen R; Jiang L; Li H; Wu P; Li L
J Transl Med; 2024 Apr; 22(1):352. PubMed ID: 38622667
[TBL] [Abstract][Full Text] [Related]
7. Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE
Zhang Y; Gu Y; Chen Y; Huang Z; Li M; Jiang W; Chen J; Rao W; Luo S; Chen Y; Chen J; Li L; Jia Y; Liu M; Zhou F
J Ethnopharmacol; 2021 Feb; 266():113436. PubMed ID: 33011372
[TBL] [Abstract][Full Text] [Related]
8. Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis.
Gopoju R; Panangipalli S; Kotamraju S
Free Radic Biol Med; 2018 Apr; 118():85-97. PubMed ID: 29499335
[TBL] [Abstract][Full Text] [Related]
9. Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis.
Wang JK; Li Y; Zhao XL; Liu YB; Tan J; Xing YY; Adi D; Wang YT; Fu ZY; Ma YT; Liu SM; Liu Y; Wang Y; Shi XJ; Lu XY; Song BL; Luo J
Circulation; 2022 Mar; 145(9):675-687. PubMed ID: 35189703
[TBL] [Abstract][Full Text] [Related]
10. Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice.
Dong P; Pan L; Zhang X; Zhang W; Wang X; Jiang M; Chen Y; Duan Y; Wu H; Xu Y; Zhang P; Zhu Y
J Ethnopharmacol; 2017 Feb; 198():479-488. PubMed ID: 28119096
[TBL] [Abstract][Full Text] [Related]
11. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
12. PARP-1 inhibitor alleviates liver lipid accumulation of atherosclerosis
Sheng Y; Meng G; Zhou Z; Du R; Wang Y; Jiang M
Mol Omics; 2023 Aug; 19(7):560-573. PubMed ID: 37249474
[No Abstract] [Full Text] [Related]
13. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S
J Lipid Res; 2014 Nov; 55(11):2370-9. PubMed ID: 25258384
[TBL] [Abstract][Full Text] [Related]
14. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
[TBL] [Abstract][Full Text] [Related]
15. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
[TBL] [Abstract][Full Text] [Related]
17. Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathway.
Hou C; Jiang X; Sheng W; Zhang Y; Lin Q; Hong S; Zhao J; Wang T; Ye X
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117240. PubMed ID: 37777030
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
[TBL] [Abstract][Full Text] [Related]
19. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice.
Hartman HB; Gardell SJ; Petucci CJ; Wang S; Krueger JA; Evans MJ
J Lipid Res; 2009 Jun; 50(6):1090-100. PubMed ID: 19174369
[TBL] [Abstract][Full Text] [Related]
20. The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.
Miranda MX; van Tits LJ; Lohmann C; Arsiwala T; Winnik S; Tailleux A; Stein S; Gomes AP; Suri V; Ellis JL; Lutz TA; Hottiger MO; Sinclair DA; Auwerx J; Schoonjans K; Staels B; Lüscher TF; Matter CM
Eur Heart J; 2015 Jan; 36(1):51-9. PubMed ID: 24603306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
